Jeff Yass’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-16,300
Closed -$182K – 13419
2025
Q2
$182K Buy
+16,300
New +$204K ﹤0.01% 11307

Other funds holding NPCE

Jeff Yass's NPCE Position: Q3 2026 in Review

Jeff Yass sold out of Neuropace (NPCE) in Q3 2026, closing a stake of 10,154 shares — an estimated $161K sold.

Jeff Yass first reported a position in NPCE in Q1 2023 and held it in 9 quarters. The position peaked at $2.69M in Q1 2024. 105 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • Jeff Yass reported no remaining Neuropace position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 10,154 Neuropace shares in Q3 2026, an estimated $161K.
  • Jeff Yass first reported a position in Neuropace in Q1 2023 and held it in 9 quarters.
  • Jeff Yass's Neuropace position peaked at $2.69M in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.